Mycophenolate Mofetil for the Management of Autoimmune Bullous Diseases

Marina Eskin-Schwartz; Michael David; Daniel Mimouni

doi:10.1016/j.det.2011.06.012

Mycophenolate Mofetil for the Management of Autoimmune Bullous Diseases

Marina Eskin-Schwartz, Michael David, Daniel Mimouni

Research output: Contribution to journal › Review article › peer-review

16 Scopus citations

Abstract

Immunosuppressive agents such as azathioprine, cyclophosphamide, and mycophenolate mofetil (MMF) are now widely used in the treatment of autoimmune bullous diseases. This article reviews the use of MMF for the treatment of several bullous conditions, and assesses the evidence gathered from clinical trials and case series. According to numerous case series, MMF could be of value in treating refractory disease. The few randomized clinical trials conducted to date of patients with pemphigus and bullous pemphigoid report a similar efficacy for MMF to other immunosuppressants.

Original language	English
Pages (from-to)	555-559
Number of pages	5
Journal	Dermatologic Clinics
Volume	29
Issue number	4
DOIs	https://doi.org/10.1016/j.det.2011.06.012
State	Published - 1 Oct 2011
Externally published	Yes

Keywords

Autoimmune bullous diseases
Immunosuppression
Mycophenolate mofetil
Mycophenolic acid

ASJC Scopus subject areas

Dermatology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.det.2011.06.012

Cite this

@article{76158dabd845414e9a8e29adf8ecfbb4,

title = "Mycophenolate Mofetil for the Management of Autoimmune Bullous Diseases",

abstract = "Immunosuppressive agents such as azathioprine, cyclophosphamide, and mycophenolate mofetil (MMF) are now widely used in the treatment of autoimmune bullous diseases. This article reviews the use of MMF for the treatment of several bullous conditions, and assesses the evidence gathered from clinical trials and case series. According to numerous case series, MMF could be of value in treating refractory disease. The few randomized clinical trials conducted to date of patients with pemphigus and bullous pemphigoid report a similar efficacy for MMF to other immunosuppressants.",

keywords = "Autoimmune bullous diseases, Immunosuppression, Mycophenolate mofetil, Mycophenolic acid",

author = "Marina Eskin-Schwartz and Michael David and Daniel Mimouni",

year = "2011",

month = oct,

day = "1",

doi = "10.1016/j.det.2011.06.012",

language = "English",

volume = "29",

pages = "555--559",

journal = "Dermatologic Clinics",

issn = "0733-8635",

publisher = "W.B. Saunders",

number = "4",

}

TY - JOUR

T1 - Mycophenolate Mofetil for the Management of Autoimmune Bullous Diseases

AU - Eskin-Schwartz, Marina

AU - David, Michael

AU - Mimouni, Daniel

PY - 2011/10/1

Y1 - 2011/10/1

N2 - Immunosuppressive agents such as azathioprine, cyclophosphamide, and mycophenolate mofetil (MMF) are now widely used in the treatment of autoimmune bullous diseases. This article reviews the use of MMF for the treatment of several bullous conditions, and assesses the evidence gathered from clinical trials and case series. According to numerous case series, MMF could be of value in treating refractory disease. The few randomized clinical trials conducted to date of patients with pemphigus and bullous pemphigoid report a similar efficacy for MMF to other immunosuppressants.

AB - Immunosuppressive agents such as azathioprine, cyclophosphamide, and mycophenolate mofetil (MMF) are now widely used in the treatment of autoimmune bullous diseases. This article reviews the use of MMF for the treatment of several bullous conditions, and assesses the evidence gathered from clinical trials and case series. According to numerous case series, MMF could be of value in treating refractory disease. The few randomized clinical trials conducted to date of patients with pemphigus and bullous pemphigoid report a similar efficacy for MMF to other immunosuppressants.

KW - Autoimmune bullous diseases

KW - Immunosuppression

KW - Mycophenolate mofetil

KW - Mycophenolic acid

UR - http://www.scopus.com/inward/record.url?scp=80052883255&partnerID=8YFLogxK

U2 - 10.1016/j.det.2011.06.012

DO - 10.1016/j.det.2011.06.012

M3 - Review article

AN - SCOPUS:80052883255

SN - 0733-8635

VL - 29

SP - 555

EP - 559

JO - Dermatologic Clinics

JF - Dermatologic Clinics

IS - 4

ER -

Mycophenolate Mofetil for the Management of Autoimmune Bullous Diseases

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this